A cancer vaccine based on the marine antimicrobial peptide pardaxin (GE33) for control of bladder-associated tumors

Han-Ning HuangJyh-Yih Chen


The marine antimicrobial peptide (AMP) GE33, also known as pardaxin, possesses antimicrobial and anticancer properties, and modulates host signaling. GE33 has cytotoxic effects on murine bladder carcinoma (MBT-2) cells. Here, we investigated the potential of GE33 combined with inactivated MBT-2 as a cancer vaccine. The presence of up to 12.5 μg of GE33 did not inhibit the proliferation or endogenous nitrous oxide (NO) levels of RAW264.7 cells. However, the secretion of MCP-1, IL-6, and IL-12 by RAW264.7 cells was affected by GE33. We proceeded to test the effectiveness of the vaccine by immunizing mice at 7, 14, and 21 days of age, and injecting live MBT-2 cells on the 28th day. Tumor growth by the 58th day was attenuated in mice treated with the vaccine, as compared to the control group. Induction of MBT-2 specific-tumor antigens was increased in mice immunized with our vaccine. Furthermore, activation of T-cell receptors, cytotoxic T-cells, and NK cells was enhanced, and these showed high specificity for targeting tumor cells. Finally, immunization controlled excess recruitment of monocytes, lymphocytes, T-helper cells, and NK cells, and decreased the expression of VEGF. This report provides empirical evidence that our GE33-b...Continue Reading


Dec 16, 1980·Biochimica Et Biophysica Acta·N Primor, A T Tu
Jan 1, 1997·Urological Research·F Jiang, X M Zhou
Oct 18, 2002·Biopolymers·Olulanu H AinaKit S Lam
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Aug 3, 2004·International Journal of Urology : Official Journal of the Japanese Urological Association·Satoko HikosakaSadao Kamidono
Jul 13, 2005·Cancer Immunology, Immunotherapy : CII·K L Knutson, M L Disis
Nov 11, 2008·Cancer Immunology, Immunotherapy : CII·Manuela IeroLicia Rivoltini
Nov 5, 2010·Clinical and Vaccine Immunology : CVI·Luigi BuonaguroFranco M Buonaguro
Mar 24, 2011·Cancer Research·Alyssa D Gregory, A McGarry Houghton
May 12, 2011·Peptides·Jung-Chieh HsuJyh-Yih Chen
Nov 30, 2011·Cancer Research·Takashi TanikawaWeiping Zou
May 29, 2012·Current Pharmaceutical Design·D B Vendramini-Costa, J E Carvalho
Oct 24, 2012·Critical Reviews in Oncology/hematology·Orazio CaffoEnzo Galligioni
Dec 5, 2012·The Journal of Experimental Medicine·Jing NiAdelheid Cerwenka
Dec 25, 2012·Oncoimmunology·Erika VacchelliLorenzo Galluzzi
Jan 15, 2013·Journal of Amino Acids·Jyothi Thundimadathil
Jan 17, 2013·European Journal of Immunology·Magali TermeEric Tartour
May 10, 2013·Nature Biotechnology·Jeffrey L Fox


Feb 11, 2016·Immunotherapy·Sean G Smith, David A Zaharoff
Jul 28, 2015·Peptides·João Pinto da CostaRui Vitorino
Mar 17, 2017·Journal of Chemical Information and Modeling·Majid JafariFarahnoosh Doustdar
Dec 27, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yinglin ZhengJiyan Pang
Jun 27, 2019·Protein and Peptide Letters·Piyush Baindara, Santi M Mandal
Mar 28, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Wu-Ching UenCheng-Jeng Tai
Apr 30, 2021·Pharmacology & Therapeutics·Pooja JainMunira Momin

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.